% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • agnostinvesting agnostinvesting Nov 18, 2011 9:54 AM Flag

    Are the big investment houses selling this stock?

    With the stock collapsing I wonder who is selling the stock? Are the major institutional investors selling or holding VRTX after this decline?

    How can we find if the big institutions are selling or holding?

    I guess if the big major holders are selling the stock and reducing their large positions will be a bad sign for all the small investors thinking to hold for a recovery. What is your perspective on this?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Avg Vol (3 month)3: 3,308,000
      Avg Vol (10 day)3: 5,303,510
      Shares Outstanding5: 208.57M
      Float: 206.40M
      % Held by Insiders1: 0.72%
      % Held by Institutions1: 97.40%
      Shares Short (as of Oct 31, 2011)3: 10.33M
      Short Ratio (as of Oct 31, 2011)3: 2.60
      Short % of Float (as of Oct 31, 2011)3: 5.90%
      Shares Short (prior month)3: 10.84M

      above stats from Yahoo , but I think there lag time.. and these numbers are not up to date at all

      This stock has wipe me out, I got in high 50s..hoping after approval it will be doubled ...dead wrong again ( same think happned with HGSI to me... )

      lost half of my investment in this..

      VRTX has lost almost 5B market CAP..

      so it is clear to me many funds have dumped this stocks... from past 3 months..

      Only hopes I see someone might buyout this company and

      That is reason I am holding it.. even it is pain to see every day you are loosing your underwear..

      All Hedge funds are spreading bad rumor about this company.. which is completely baselss…

      • 1 Reply to usazulu
      • if you bought in at $50 and were expecting to get out at $100 with just the news of approval then you made a very foolish and very ill researched investment.

        anyone following the stock would know that approval was mostly priced in already. the long term trend of the stock will depend almost entirely on sales figures and additional drugs being brought to market. highest estimates i have seen at any point for the next year were around $80. what is driving the short term share price is anyone's guess (which is my clever way of saying: rampant speculation).

    • Large institutional holders of Vertex stock would be unlikely to trade those kinds of volumes in the retail market. Instead, they tend to trade large blocks of shares with one another. I think it is fair to say that Vertex the stock, not the company, is broken. To me, that means the stock price no longer correlates with the value, the earnings or the prospects of the company. There is negative momentum currently and that can make the price go down for no other reason than that the price has been going down. Traders and hedge funds can make money selling short day after day, especially with no uptick rule in effect. Biotech stocks, like all risky sectors, tend to overreact on the upside as well as the downside.

    • I'd like to know the answer to that as well. When do they have to file after a sale? Is it quarterly or 30 days? Anybody?

93.15+2.77(+3.06%)May 31 4:00 PMEDT